Centessa Pharmaceuticals Announces Third Quarter 2021 Financial Results and Business Updates

NEXT STORY
Global Neurological Therapies Market Research Report 2021: Competitive Landscape and Pipeline Analysis Focusing Specifically on Therapeutic Interventions for Neurodegenerative Diseases
PREV STORY
atai Life Sciences Reports Third Quarter 2021 Financial Results and Corporate Update
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Provation and the Australian Commission on Safety and Quality in Health Care strive to improve colonoscopy documentation with new requirements and technology

author_avatar
NASDAQ Market News

Cellectar Biosciences Announces INC Research as the CRO for the Phase II Trial of CLR 131 in Hematologic Malignancies; $2M NCI Grant Covers Half of Study Cost, with Potential Option to Pursue Additional $3M for Pivotal Trial

MADISON, Wis., Nov. 15, 2016 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq:CLRB) (the “company”), ...

author_avatar
NASDAQ Market News

Los Angeles Plastic Surgeon Christine Petti, MD & Spa Bella Are “South Bay’s Best 2018”

The 27th annual Daily Breeze Readers Choice Awards delivered three wins to Dr. Petti ...

author_avatar
NASDAQ Market News